Trials / Unknown
UnknownNCT01595984
Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME)
Randomized, Multicenter, Open-label, Comparative Study of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI), Associating Myfortic ® and Neoral ® Compared to a CNI-free Treatment, Combining Myfortic ® and Certican ® , in Adult Patients With de Novo Renal Transplant
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this protocol is to compare the impact on renal function of two different immunosuppressive regimens in patients with de novo renal transplant. Renal function will be accurately evaluated by measuring the clearance of iohexol. The protocol will also evaluate the efficacy and safety in a short term of these two different immunosuppressive regimens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cyclosporin + mycophenolate mofetil | antirejection drug, renal transplantation |
| DRUG | everolimus + mycophenolate mofetil | antirejection drug, renal transplantation |
Timeline
- Start date
- 2012-05-03
- Primary completion
- 2018-08-01
- Completion
- 2018-08-01
- First posted
- 2012-05-10
- Last updated
- 2018-08-21
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01595984. Inclusion in this directory is not an endorsement.